Search results for: 'computing 2024'

29 Sep 2023  |  Global  |  Technology Research

Opportunity Assessment of Cloud Gaming Evolution in the 5G and 6G Era

5G/6G Standards and Complementary Infrastructure Enable Cloud Adoption in a Rapidly Evolving Gaming Industry

Infographics

×

The cloud gaming sector is set to experience rapid growth because of the improvements in infrastructure and the availability of cost-effective technological solutions. The gaming industry is expanding with the increased adoption of mobile devices and penetration of 5G technology, which will lead to tough competition among gaming companies. Althoug...

This Frost & Sullivan research service focuses on US Department of Defense (DoD) cybersecurity budget spending and contracts. This study is an outline of the US DoD cybersecurity market. Cybersecurity systems are used to protect information technology (IT) networks, sensors, combat systems, and data across the enterprise from exploitation or destr...

The global medical devices industry was valued at $545.38 billion in 2024 and is expected to reach $801.34 billion in 2029. Companies continue to focus on and invest in new product development to ensure long-term and sustained growth. The cardiovascular devices market attracted significant investments, especially in transcatheter technologies for m...

17 Sep 2021  |  Global  |  Frost Radar

Frost Radar™: Global SD-WAN Vendor Market, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

At the peak of the COVID-19 pandemic in 2020, software-defined wide area network (SD-WAN) vendors witnessed a surge in demand for SD-WAN technology to extend to remote workers. The business case for doing so is solid. As businesses across industries are embracing the public cloud to host key applications, and with advances in residential broadband ...

The Sensor Technology Opportunity Engine provides profiles of innovations related to software-defined vision sensor technology integrating pixel-level computing for low-power, real-time edge perception; flexible direct-conversion X-ray detector technology enabling conformal digital radiography for medical imaging and applications requiring adaptabl...

01 Feb 2021  |  North America  |  Market Research

Digital Transformation in Imaging Powering the Next Wave of Growth in Informatics

Future Growth Potential Enhanced by Growth Opportunities in Enterprise Imaging IT

Infographics

×

The global medical imaging and informatics industry is undergoing rapid change with the emergence of new technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, making it necessary for industry participants to continuously innovate to maintain their competitive edge. New technologies such as A...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

The global waste management industry is transitioning toward greater digital technology adoption with the growing availability and deployment of smart solutions such as smart bins and fleet management, cloud computing, customer interfaces, waste tracking systems, and AI robotic sorting. These solutions will significantly improve waste collection, t...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...